The Z type variation of human alpha 1-antitrypsin causes a protein folding defect
- PMID: 7664092
- DOI: 10.1038/nsb0595-363
The Z type variation of human alpha 1-antitrypsin causes a protein folding defect
Abstract
Emphysema is often associated with the Z type mutation of alpha 1-antitrypsin, which causes aggregation of the molecule in the liver and consequent plasma deficiency. The aggregation appears to be due to loop-sheet polymerization, although why the mutant protein polymerizes in vivo is unclear. Here we show that, unlike wild type antitrypsin, which folds in minutes, the folding of Z type alpha 1-antitrypsin is extremely slow. Once folded, however, the native Z protein shows substantial stability towards urea and incubation at 37 degrees C. The folding defect in Z antitrypsin leads to accumulation of an intermediate and it is the intermediate rather than the native protein which has a high tendency to aggregate.
Similar articles
-
Retarded protein folding of deficient human alpha 1-antitrypsin D256V and L41P variants.Protein Sci. 2004 Mar;13(3):694-702. doi: 10.1110/ps.03356604. Epub 2004 Feb 6. Protein Sci. 2004. PMID: 14767073 Free PMC article.
-
A thermostable mutation located at the hydrophobic core of alpha 1-antitrypsin suppresses the folding defect of the Z-type variant.J Biol Chem. 1995 Apr 14;270(15):8597-601. doi: 10.1074/jbc.270.15.8597. J Biol Chem. 1995. PMID: 7721761
-
Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver.Clin Sci (Lond). 1994 May;86(5):489-95. doi: 10.1042/cs0860489. Clin Sci (Lond). 1994. PMID: 8033502 Review.
-
Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin.Biochemistry. 1993 Jan 19;32(2):500-8. doi: 10.1021/bi00053a014. Biochemistry. 1993. PMID: 8422359
-
Alpha(1)-antitrypsin deficiency, liver disease and emphysema.Int J Biochem Cell Biol. 2003 Jul;35(7):1009-14. doi: 10.1016/s1357-2725(02)00250-9. Int J Biochem Cell Biol. 2003. PMID: 12672469 Review.
Cited by
-
Retarded protein folding of deficient human alpha 1-antitrypsin D256V and L41P variants.Protein Sci. 2004 Mar;13(3):694-702. doi: 10.1110/ps.03356604. Epub 2004 Feb 6. Protein Sci. 2004. PMID: 14767073 Free PMC article.
-
Intracellular processing of alpha1-antitrypsin.Proc Am Thorac Soc. 2010 Nov;7(6):376-80. doi: 10.1513/pats.201001-011AW. Proc Am Thorac Soc. 2010. PMID: 21030516 Free PMC article. Review.
-
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.Drug Des Devel Ther. 2011;5:391-405. doi: 10.2147/DDDT.S14018. Epub 2011 Aug 17. Drug Des Devel Ther. 2011. PMID: 21966212 Free PMC article. Review.
-
Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs.Mol Biol Cell. 2002 Aug;13(8):2639-50. doi: 10.1091/mbc.e02-02-0068. Mol Biol Cell. 2002. PMID: 12181335 Free PMC article.
-
Probing the local conformational change of alpha1-antitrypsin.Protein Sci. 2007 Sep;16(9):1842-50. doi: 10.1110/ps.072911607. Epub 2007 Jul 27. Protein Sci. 2007. PMID: 17660256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical